Dance Biopharm Inc.   Report issue

For profit Phase 2
Founded: Brisbane CA United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2013
NCT02713841
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Dance Biopharm Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

insulin human (humulin) (4 trials)

insulin lispro (humalog) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2